The Association between Gestational Diabetes and the Microbiome: A Systematic Review and Meta-Analysis

Microorganisms. 2023 Jul 4;11(7):1749. doi: 10.3390/microorganisms11071749.

Abstract

Gestational diabetes, affecting about 10% of pregnancies, is characterized by impaired glucose regulation and can lead to complications for health of pregnant women and their offspring. The microbiota, the resident microbes within the body, have been linked to the development of several metabolic conditions. This systematic review with meta-analysis aims to summarize the evidence on the differences in microbiota composition in pregnant women with gestational diabetes and their offspring compared to healthy pregnancies. A thorough search was conducted in the PubMed, Scopus, and Web of Science databases, and data from 21 studies were analyzed utilizing 41 meta-analyses. In the gut microbiota, Bifidobacterium and Alistipes were found to be more abundant in healthy pregnancies, while Roseburia appears to be more abundant in gestational diabetes. The heterogeneity among study findings regarding the microbiota in the meconium is considerable. The placental microbiota exhibited almost no heterogeneity, with an increased abundance of Firmicutes in the gestational diabetes group and a higher abundance of Proteobacteria in the control. The role of the microbiota in gestational diabetes is reinforced by these findings, which additionally point to the potential of microbiome-targeted therapies. To completely comprehend the interactions between gestational diabetes and the microbiome, standardizing methodologies and further research is necessary.

Keywords: dysbiosis; gestational diabetes; microbiome; microbiota; pregnancy.

Publication types

  • Review

Grants and funding

This research was funded by national funds through FCT—Portuguese Foundation for Science and Technology, under the scope of the Cardiovascular R&D Center—UnIC (UIDB/00051/2020 and UIDP/00051/2020).